Deep Track Capital, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Nektar Therapeutics Common Stock, par value $0.0001 (NKTR)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Nektar Therapeutics Common Stock, par value $0.0001
Symbol
NKTR
Shares outstanding
185M shares
Disclosed Ownership
1.98M shares
Ownership
1.07%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 08:43:38 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 1.07% 1.98M 0 1.98M /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 1.07% 1.98M 0 1.98M /s/ David Kroin David Kroin, Director
David Kroin 1.07% 1.98M 0 1.98M /s/ David Kroin David Kroin